EY Health Sciences & Wellness podcast series

In this episode of the EY Health Sciences and Wellness Experience podcast, host Patrick T. O'Sullivan discusses how AI is currently being used to support pharmaceutical manufacturing and supply chain.

In this episode of the EY Health Sciences and Wellness Experience Podcast, Aloha McBride and her guests explore health inequity, sustainable change and environmental impact of the health industry.   Our panel of experts discuss the evolution of sustainability in health. The explore where organizations can start on their sustainability journey, how they can create sustainable change, and reduce cli...

In today's episode we focus on the EY report on the Pharma supply chains of the future, and discuss the impact of global events and how a new supply chain model can emerge in the pharma industry.   The speakers discuss the future of pharmaceutical supply chains in the wake of the COVID-19 pandemic and other geopolitical events and shifts that are unfolding around us. The discussion covers the impa...

In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact.   Together they review the growing importance of sustainable health solutions, ESG in healthcare and sustainability reporting in the Health Sciences and Wellness industry. Learn how ESG reporting and the informa...

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, talks with Nancy Flores, Executive Vice President & Chief Information and Technology Officer for McKesson Corporation and look into innovation in healthcare and health care data science.   They discuss the unique complexities of healthcare – a sector with new ent...

In this episode of the EY Health Sciences and Wellness Experience podcast we focus on women in health. Join Pamela Spence, EY Global Health Sciences and Wellness Leader, as she speaks with Trecilla Lobo, SVP, People, BenevolentAI, Rabia Khan, Founder/CEO, Ladder Therapeutics, and Samin Saeed, UK Chief Scientific Officer and Medical Director, Novartis.   Together they discuss their own unique caree...

In this episode of the EY Health Sciences and Wellness Experience Podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, Jackie Hunter, Board Director of Benevolent AI and Ridwaan Jhetam, VP Global Medical for Haematology, BMS, discuss the importance of data science in healthcare and how it can help redesign the health experience and the future of health.   In this wide-ranging dis...

There are 2,600 gen and cell therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. As the evolution of medicine continues, the future looks promising for advancements in cell and gene therapy.   In this podcast,...

In this episode, we delve into the global challenge of addressing health inequality with Dr. Yele Aluko, EY Chief Medical Officer, and Dr. David Rhew, Microsoft Chief Medical Officer. As experienced physicians, they share their passion for finding opportunities to provide health equity and discuss the root causes of disparities and how unbiased digital medicine can help.   We learn that health car...

In this first episode of our EY Health Sciences and Wellness Experience podcast series, we explore the emerging and much needed age of "Health Experience" and the disruptive health innovation emerging in the aftermath of the covid 19 pandemic.   The Covid 19 impact on healthcare was immense and Health Sciences and Wellness industry has never been as "front and centre" in our lives as it has been i...